Polymyxin B Injection, Powder, For Solution
Product Images NDC 70594-049

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Polymyxin B (NDC 70594-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xellia Pharmaceuticals Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Polymyxin 01)

Chemical structure diagram of Polymyxin B Sulfate, showing its peptide chain and side groups with molecular components labeled, including Dab, Thr, Leu, Phe, and the sulfate salt (H2SO4).*

FDA Label Image

Principal Display Panel (500,000 unit Vial Carton)

Label for Polymyxin B for Injection, USP 500,000 units per vial, sterile powder for solution. The product is supplied in 10 sterile vials and labeled for hospital use only. Manufactured by Xellia Pharmaceuticals USA LLC, the label specifies use for intramuscular, intravenous, and intrathecal administration. The box features dosage warnings, storage instructions, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.